SCHEMBL6999002

SCHEMBL6999002

COc1cccc(CC(OC(=O)C(F)(F)F)C2(NC(=O)C(F)(F)F)CCNCC2)c1OC

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.35
CYP2D6 P10635 2/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetamide SCHEMBL6991362 0.72 L3MBTL1 (0.36) ALDH1A1LMNAL3MBTL1TP53PKM
Trifluoroacetamide SCHEMBL6993217 0.68 SLC6A2 (0.40) ALDH1A1LMNAL3MBTL1TP53
SCHEMBL4071874 0.66 SIGMAR1 (0.43) CYP2D6USP2KMT2AMEN1PKM
Formaldehyde SCHEMBL9556537 0.66 SIGMAR1 (0.43) CYP2D6USP2KMT2AMEN1PKM
SCHEMBL5498128 0.65 SIGMAR1 (0.49) ALDH1A1CYP2D6USP2KMT2AMEN1
SCHEMBL6992863 0.65 L3MBTL1 (0.45) ALDH1A1LMNASMN1; SMN2L3MBTL1
SCHEMBL6989780 0.63 SLC6A2 (0.46) ALDH1A1LMNACYP2D6L3MBTL1TP53
SCHEMBL28958682 0.63 OPRK1 (0.47) ALDH1A1LMNASMN1; SMN2KMT2AMEN1
SCHEMBL490857 0.63 ALDH1A1 (0.53) ALDH1A1HTTKMT2AMEN1HIF1A
Trifluoroacetic Acid SCHEMBL4071872 0.62 SIGMAR1 (0.43) ALDH1A1CYP2D6USP2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015446-B1 (4-PIPERIDINYL)-1H-2-BENZOPYRAN DERIVATIVES USEFUL AS ANTIPSYCHOTIC AGENTS AVENTIS PHARMA INC (US) 2003-04-02 EP disclosed
US-6004982-A SIDE EFFECT REDUCTION; SCHIZOPHRENIA HOECHST MARION ROUSSEL, INC. (US) 1999-12-21 US disclosed